|
ZDHHC20 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.947550E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.46270000000748E-05 |
| Normal-vs-Stage2 |
2.277700E-02 |
| Normal-vs-Stage3 |
5.788400E-02 |
| Normal-vs-Stage4 |
1.022640E-01 |
| Stage1-vs-Stage2 |
6.017000E-01 |
| Stage1-vs-Stage3 |
2.421800E-01 |
| Stage1-vs-Stage4 |
8.960400E-01 |
| Stage2-vs-Stage3 |
6.501600E-01 |
| Stage2-vs-Stage4 |
8.175800E-01 |
| Stage3-vs-Stage4 |
5.486000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.969500E-04 |
| Normal-vs-AfricanAmerican |
9.049700E-04 |
| Normal-vs-Asian |
1.219620E-02 |
| Caucasian-vs-AfricanAmerican |
5.700000E-01 |
| Caucasian-vs-Asian |
6.488200E-01 |
| AfricanAmerican-vs-Asian |
7.109200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.53180000000064E-05 |
| Normal-vs-Female |
6.113400E-01 |
| Male-vs-Female |
5.200100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.499300E-03 |
| Normal-vs-Extreme_Weight |
7.18390000042923E-07 |
| Normal-vs-Obese |
1.443960E-02 |
| Normal-vs-Extreme_Obese |
1.063230E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.972030E-01 |
| Normal_Weight-vs-Obese |
5.098000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.733800E-01 |
| Extreme_Weight-vs-Obese |
9.115800E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.510200E-01 |
| Obese-vs-Extreme_Obese |
2.055000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.088560E-01 |
| Normal-vs-Age(41-60Yrs) |
7.298800E-03 |
| Normal-vs-Age(61-80Yrs) |
6.754000E-04 |
| Normal-vs-Age(81-100Yrs) |
3.72130000000359E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.935200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.297600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.139570E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.925800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.577300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.270200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.56778000000024E-05 |
| Normal-VS-Type2 PRCC |
2.223600E-03 |
| Normal-VS-KIRP CIMP |
7.117800E-01 |
| Normal-VS-Unclassified PRCC |
4.883600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.676000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.503600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.179800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.530000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.874350E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.904400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.98679999999785E-05 |
| Normal-vs-N1 |
2.126800E-01 |
| Normal-vs-N2 |
2.101200E-01 |
| N0-vs-N1 |
3.380000E-02 |
| N0-vs-N2 |
5.255600E-01 |
| N1-vs-N2 |
7.286600E-01 |
|
|
